Dr. Vallabhaneni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615
Education & Training
- University of Pennsylvania Health SystemFellowship, Cardio-Oncology, Cardiac Imaging, 2021
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardio-Oncology, Cardiac Imaging, 2020 - 2020
- St Luke's University HospitalFellowship, Cardiovascular Disease, 2017 - 2020
- Guntur Medical College NTRClass of 2011
Certifications & Licensure
- TX State Medical License 2021 - 2025
- MO State Medical License 2020 - 2022
- PA State Medical License 2017 - 2022
- OH State Medical License 2016 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Certification Board of Nuclear CardiologyNuclear Cardiology
- International Cardio-Oncology SocietyCardio-Oncology
- National Board of EchocardiographyEchocardiography
Publications & Presentations
PubMed
- 92 citationsCOVID-19 and Hypercoagulability: A Review.Asim Kichloo, Kirk Dettloff, Michael Aljadah, Michael Albosta, Shakeel Jamal
Clinical and Applied Thrombosis/hemostasis. 2020-10-19 - 4 citationsCardiovascular disease and chimeric antigen receptor cellular therapy.Anjali Rao, Andrew Stewart, Mahmoud Eljalby, Praveen Ramakrishnan, Larry D Anderson Jr
Frontiers in Cardiovascular Medicine. 2022-01-01 - 10 citationsMarijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utilityAsim Kichloo, Michael Albosta, Michael Aljadah, Zain El-Amir, Ghazaleh Goldar
SAGE Open Medicine. 2021-03-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: